====== Tunicamycin 0.04 to 0.075μM on day4 R07 exp419 ======
==== Mechanism of Action ====
Inhibits GlcNAc phosphotransferase (GPT), blocks N-linked glycoslylation, induces protein unfolding in ER, nucleoside antibiotic
* **Class / Subclass 1:** Proteostasis / Unfolded Protein Response Activator
* **Class / Subclass 2:** Infectious Disease / Antibiotic
==== Technical Notes ====
* **PubChem Name:** %%Tunicamycin from Streptomyces sp.%%
* **Synonyms:** N/A
* **CAS #:** 11089-65-9
* **PubChem CID:** [[https://pubchem.ncbi.nlm.nih.gov/compound/16220051|16220051]]
* **IUPAC:** %%(E)-N-[(2S,3R,4R,5R,6R)-2-[(2S,3S,4S,5R,6S)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[(2R)-2-[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl]-4,5-dihydroxyoxan-3-yl]-12-methyltridec-2-enamide%%
* **INCHI Name:** InChI=1S/C37H60N4O16/c1-18(2)12-10-8-6-4-5-7-9-11-13-23(45)39-26-30(50)27(47)21(54-36(26)57-35-25(38-19(3)43)29(49)28(48)22(17-42)55-35)16-20(44)33-31(51)32(52)34(56-33)41-15-14-24(46)40-37(41)53/h11,13-15,18,20-22,25-36,42,44,47-52H,4-10,12,16-17H2,1-3H3,(H,38,43)(H,39,45)(H,40,46,53)/b13-11+/t20-,21-,22+,25+,26-,27+,28+,29+,30-,31+,32-,33-,34-,35+,36+/m1/s1
* **INCHI Key:** YJQCOFNZVFGCAF-WPTOCQRYSA-N
* **Molecular Weight:** 816.9
* **Canonical SMILES:** CC(C)CCCCCCCCC=CC(=O)NC1C(C(C(OC1OC2C(C(C(C(O2)CO)O)O)NC(=O)C)CC(C3C(C(C(O3)N4C=CC(=O)NC4=O)O)O)O)O)O
* **Isomeric SMILES:** CC(C)CCCCCCCC/C=C/C(=O)N[C@@H]1[C@H]([C@H]([C@H](O[C@H]1O[C@H]2[C@H]([C@@H]([C@H]([C@@H](O2)CO)O)O)NC(=O)C)C[C@H]([C@@H]3[C@H]([C@H]([C@@H](O3)N4C=CC(=O)NC4=O)O)O)O)O)O
* **Molecular Formula:** C37H60N4O16
{{:chemogenomics:structures:chem-0251.svg?nolink}}
* **Supplier Name:** Sigma-Aldrich
* **Catalog #:** T7765
* **Lot #:** 037M4047V
* **HRMS (ESI-TOF) m/z:** (M+NH4)+ Calcd for C37H60N4O16 834.43426; found 834.4337
* **Platform ID:** Tunicamycin
* **Min:** -6.5253; **Max:** 80.8037
{{:chemogenomics:dose_response:dr_411.png?nolink&500 |}}
\\
\\
\\
\\
|< 300px 100px 200px >|
^ IC ^ Concentration (µM) ^
| IC10 |N/A |
| IC20 |0.0211 |
| IC30 |0.0328 |
| IC40 |0.0492 |
| IC50 |0.0748 |
| IC60 |N/A |
| IC70 |N/A |
| IC80 |N/A |
| IC90 |N/A |
\\
==== Screen Summary ====
* **Round**: 07
* **Dose**: 0.04-0.075µM
* **Days of incubation**: 8
* **Doublings**: 5.4
* **Numbers of reads**: 14285538
==== Screen Results ====
^Sensitive/Resistant hits (FDR<0.05)^CRANKS^Score Plot^Top 30 Genes^Screen Similarity^Top 30 Sensitive GO terms^Top 30 Resistant GO terms^
|1/18|[[https://files.tyerslab.com/files/public/chemogenomics/cranks/Tunicamycin_0.04-0.075day4uM_Round-7_exp419.txt|Scores]]||||||
{{:chemogenomics:cranks_plots:exp419.png?nolink}}
^Gene^CRANKS Score^FDR^
|[[:human_genes:D:DPAGT1|DPAGT1]]|-3.67|<0.01|
|[[:human_genes:V:VPS25|VPS25]]|-2.66|0.23|
|[[:human_genes:P:PCYT1A|PCYT1A]]|-2.58|0.12|
|[[:human_genes:D:DRD4|DRD4]]|-2.44|0.15|
|[[:human_genes:C:CXCR4|CXCR4]]|-2.42|0.15|
|[[:human_genes:C:CDKL3|CDKL3]]|-2.39|0.15|
|[[:human_genes:E:ENY2|ENY2]]|-2.32|0.19|
|[[:human_genes:E:EIF5B|EIF5B]]|-2.32|0.54|
|[[:human_genes:G:GUCA2B|GUCA2B]]|-2.29|0.20|
|[[:human_genes:C:COX5A|COX5A]]|-2.29|0.23|
|[[:human_genes:D:DNAJC3|DNAJC3]]|-2.29|0.17|
|[[:human_genes:N:NANS|NANS]]|-2.29|0.17|
|[[:human_genes:C:CPLX1|CPLX1]]|-2.28|0.17|
|[[:human_genes:F:FOXP4|FOXP4]]|-2.27|0.20|
|[[:human_genes:D:DHRSX|DHRSX]]|-2.26|0.17|
|[[:human_genes:D:DERL2|DERL2]]|-2.23|0.19|
|[[:human_genes:F:FKBP5|FKBP5]]|-2.19|0.19|
|[[:human_genes:M:MRPS11|MRPS11]]|-2.18|0.19|
|[[:human_genes:F:FOXP3|FOXP3]]|-2.15|0.23|
|[[:human_genes:D:DYX1C1|DYX1C1]]|-2.15|0.20|
|[[:human_genes:D:DHDDS|DHDDS]]|-2.14|0.29|
|[[:human_genes:E:ERGIC2|ERGIC2]]|-2.11|0.22|
|[[:human_genes:R:RTCB|RTCB]]|-2.11|0.23|
|[[:human_genes:U:UMPS|UMPS]]|-2.11|0.59|
|[[:human_genes:C:CDIPT|CDIPT]]|-2.09|0.43|
|[[:human_genes:A:ARL1|ARL1]]|-2.09|0.22|
|[[:human_genes:A:ATG9A|ATG9A]]|-2.09|0.22|
|[[:human_genes:T:THBS4|THBS4]]|-2.08|0.22|
|[[:human_genes:F:FOXD4L1|FOXD4L1]]|-2.07|0.25|
|[[:human_genes:S:SLC22A18AS|SLC22A18AS]]|-2.06|0.23|
|[[:human_genes:I:IKBKB|IKBKB]]|2.22|0.09|
|[[:human_genes:U:UBE2V2|UBE2V2]]|2.29|0.06|
|[[:human_genes:N:NPY4R|NPY4R]]|2.29|0.12|
|[[:human_genes:T:TMEM147|TMEM147]]|2.30|0.06|
|[[:human_genes:P:POU2F1|POU2F1]]|2.31|0.16|
|[[:human_genes:A:ARHGAP28|ARHGAP28]]|2.32|0.06|
|[[:human_genes:C:CNBP|CNBP]]|2.33|0.06|
|[[:human_genes:I:IGBP1|IGBP1]]|2.38|0.30|
|[[:human_genes:S:SP2|SP2]]|2.39|0.04|
|[[:human_genes:P:PDZRN4|PDZRN4]]|2.43|0.04|
|[[:human_genes:R:RPL30|RPL30]]|2.44|0.38|
|[[:human_genes:K:KMT2D|KMT2D]]|2.44|0.03|
|[[:human_genes:C:CDK8|CDK8]]|2.60|0.03|
|[[:human_genes:C:CKAP5|CKAP5]]|2.62|0.18|
|[[:human_genes:E:EEF2|EEF2]]|2.66|0.42|
|[[:human_genes:O:OST4|OST4]]|2.67|0.17|
|[[:human_genes:R:RPN2|RPN2]]|2.73|<0.01|
|[[:human_genes:M:MGAT1|MGAT1]]|2.75|<0.01|
|[[:human_genes:N:NCLN|NCLN]]|2.78|0.02|
|[[:human_genes:S:SLC35A1|SLC35A1]]|2.82|<0.01|
|[[:human_genes:M:MPHOSPH10|MPHOSPH10]]|2.88|0.02|
|[[:human_genes:E:ELF1|ELF1]]|3.08|<0.01|
|[[:human_genes:G:GALE|GALE]]|3.17|<0.01|
|[[:human_genes:P:PDS5B|PDS5B]]|3.28|<0.01|
|[[:human_genes:T:TSC2|TSC2]]|3.73|<0.01|
|[[:human_genes:S:SCAP|SCAP]]|4.12|<0.01|
|[[:human_genes:E:EIF2AK3|EIF2AK3]]|4.42|<0.01|
|[[:human_genes:M:MAGT1|MAGT1]]|6.58|<0.01|
|[[:human_genes:S:STT3B|STT3B]]|6.72|<0.01|
|[[:human_genes:M:MFSD2A|MFSD2A]]|8.50|<0.01|
^Screen^Correlation^Plot^
|[[:results:exp420|Tunicamycin 0.04 to 0.125μM on day4 R07 exp420]]|0.246||
|[[:results:exp418|Tunicamycin 0.04μM R07 exp418]]|0.229||
{{:chemogenomics:comparison_plots:exp419_vs_exp420.png?nolink |}}
{{:chemogenomics:comparison_plots:exp418_vs_exp419.png?nolink |}}
No GO term hits below threshold. (FDR <0.05)
^GO Term^Fold Change^Genes^
|oligosaccharyltransferase complex|170.04|STT3B,MAGT1,RPN2,OST4|
|protein N-linked glycosylation via asparagine|120.14|STT3B,MAGT1,MGAT1,RPN2,OST4|
|protein N-linked glycosylation|40.05|STT3B,MAGT1,MGAT1,RPN2,OST4|